Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-24 @ 5:07 PM
NCT ID:
NCT05525650
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 19 - 65years with allergic rhinitis caused by the house dust mite antigen.
* ImmunoCAP® titer \> 3.49 kUA/L for the house dust mite antigen.
* Determined to be suitable for clinical trials as a result of laboratory tests.
Exclusion Criteria:
* Patients with uncontrolled, severe, or moderate asthma according to the Global Initiative for Asthma (GINA) guidelines.
* In case of lactation or pregnancy.
* If an infectious disease that may affect this study is identified.
* Patients with a history of rhinology surgery within 6 months prior to the first administration of the clinical investigational drug.
* If the allergy skin prick test is negative for the house dust mite antigen.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
60 Years
Study:
NCT05525650
Study Brief:
Protocol Section:
NCT05525650